Literature DB >> 2021379

Evaluation of a psychological treatment for inflammatory bowel disease.

S P Schwarz1, E B Blanchard.   

Abstract

Inflammatory bowel disease (IBD) encompasses two related gastrointestinal-tract diseases, ulcerative colitis (UC) and Crohn's Disease (CD). This study, a randomized controlled trial, compared the effectiveness of a multi-component behavioral treatment package (n = 11), which included IBD education, progressive muscle relaxation, thermal biofeedback, and training in use of cognitive coping strategies, to the effectiveness of symptom-monitoring (n = 10) as a control condition; 8 controls subsequently completed treatment. At posttreatment, the treatment group showed mean reductions on 5 symptoms, while the symptom monitoring controls showed mean reductions on all 8 symptoms. On a measure of Total Symptomatic change, the controls showed more improvement than the treated group; the treated controls at posttreatment, showed increases on all 8 symptoms. However, treated subjects perceived themselves as coping better with IBD, as feeling less IBD-related stress, and as experiencing less depression and anxiety. It is hypothesized that inherent differences may have existed between CD and UC subjects which could have led to the differences seen in treatment responses.

Entities:  

Mesh:

Year:  1991        PMID: 2021379     DOI: 10.1016/0005-7967(91)90045-5

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  19 in total

Review 1.  Psychological stress in IBD: new insights into pathogenic and therapeutic implications.

Authors:  J E Mawdsley; D S Rampton
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 3.  The psyche and the gut.

Authors:  Paul Enck; Ute Martens; Sibylle Klosterhalfen
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

Review 4.  Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease.

Authors:  Stefanie Joos
Journal:  Chin J Integr Med       Date:  2011-06-10       Impact factor: 1.978

5.  Optimizing management of Crohn's disease within a project management framework: results of a pilot study.

Authors:  Laurie Keefer; Bethany Doerfler; Caroline Artz
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

Review 6.  Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.

Authors:  Whitney Duff; Natasha Haskey; Gillian Potter; Jane Alcorn; Paulette Hunter; Sharyle Fowler
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 7.  Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

Authors:  Branislav R Filipovic; Branka F Filipovic
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

8.  Treatment of psychological co-morbidities in common gastrointestinal and hepatologic disorders.

Authors:  Antonina A Mikocka-Walus
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-04-06

9.  Inflammatory bowel disease in children: psychological and psychiatric issues.

Authors:  Parikshit Deshmukh; Gaurav Kulkarni; Jeanne Lackamp
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

10.  Crohn's disease: a patient's perspective.

Authors:  M Zutshi; T L Hull; J Hammel
Journal:  Int J Colorectal Dis       Date:  2007-07-31       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.